~~<i id='F539FD1E66'><strike id='F539FD1E66'><tt id='F539FD1E66'><pre id='F539FD1E66'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

hotspot

author：entertainment 2025-09-27 23:52:19 - browse：81

ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

Arch declined to comment on the new fundraising.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： IVF, abortion rights issues kick off Biden’s State of the Union

hotspot

Wikipedia

hotspot

knowledge

High-risebuildingsindowntownLosAngelesseenonahazymorning.FREDERICJ.BROWN/AFPviaGettyImagesTheU.S.ism

WSS

Russia strikes Ukraine's critical port facilities in Odesa after halting grain deal

India sets sights on home

New warning issued for rebooking air travel after delays, cancellations

Celebrate National Dole Whip Day for 3 days this week at Disney

UnitedHealth quietly bought dozens of outpatient centers

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

explore

hotspot

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

DOJ, FTC to increase scrutiny of all types of health care mergers

Novavax promises a turnaround & Lilly roils the obesity market

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Stanford president to resign after investigation of research

Peter Hotez and the public health issue of online harassment

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

As demand for Covid shots wanes, Moderna seeks its next success

Why the Crimean Bridge is key to Russia's war in Ukraine

hotspot

Seattle police shoot person suspected in downtown stabbing

With psoriasis trial ahead, Alumis raises $259 million

Amylyx ALS drug failure raises questions and concerns

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Resistance to cancer drugs: A new genetic explanation

Why the Crimean Bridge is key to Russia's war in Ukraine

hotspot

Wikipedia

hotspot

knowledge